Organization Announcements



Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.
Paul G. Allen Frontiers Group [to 06 Nov 2021]
Press Release
Announcing the Allen Institute for Neural Dynamics, a new neuroscience division of the Allen Institute
November 4, 2021
New Institute will study how the brain’s circuitry and activity give rise to complex behavior, decision making and memory
BARDA – U.S. Department of HHS [to 06 Nov 2021]
No new digest content identified.
BMGF – Gates Foundation [to 06 Nov 2021]
Press Releases and Statements
Bill & Melinda Gates Foundation Pledges $315 million to Support Innovations That Help Smallholder Farmers Adapt to Climate Threats
Press release
Nov 02, 2021
Bill & Melinda Gates Medical Research Institute [to 06 Nov 2021]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
CARB-X [to 06 Nov 2021]
No new digest content identified.
Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 06 Nov 2021]
:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.

Informed Consent: A Monthly Review – November 2021 is now posted here

Commentary: WHO, Member States Should Resist G20 Politicization of WHO Emergency Use Listing [EUL] “Procedures and Processes”
3 November 2021
David R Curry
CEPI – Coalition for Epidemic Preparedness Innovations [to 06 Nov 2021]
Latest News
Nipah virus: The deadly illness without a vaccine
Causing rapidly progressive illness, including inflammation of the brain, Nipah virus is one of the deadliest pathogens known to infect humans. We must advance research and develop tools to protect against this disease.
05 Nov 2021

CEPI announces first funding awards in quest to develop ‘variant-proof’ COVID-19 vaccines
Partnerships with MigVax Ltd and University of Saskatchewan’s Vaccine & Infectious Disease Organization kick off programme to develop broadly protective vaccines against COVID-19 variants and other coronaviruses.
04 Nov 2021
[See COVID above for detail]

Q2 Solutions Beijing joins CEPI’s global network of COVID-19 vaccine testing labs
This network is the largest and only global group launched to harmonise the assessment of COVID-19 vaccines currently undergoing preclinical and clinical trials. Q2 Solutions laboratory in the US joined the network last year.
02 Nov 2021
DARPA – Defense Advanced Research Projects Agency [to 06 Nov 2021
No new digest content identified.
Duke Global Health Innovation Center [to 06 Nov 2021]
Our Blog
No new digest content identified.
EDCTP [to 06 Nov 2021]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
02 November 2021
EDCTP at COVID CIRCLE online event

02 November 2021
EDCTP Prizes 2020 awarded at the Tenth EDCTP Forum
EDCTP awarded its prizes for research excellence and the Pascoal Mocumbi Prize at the Tenth EDCTP Forum that was held from 17-21 October 2021 from Maputo, Mozambique & virtual.

Emory Vaccine Center [to 06 Nov 2021]
Vaccine Center News
No new digest content identified.
European Vaccine Initiative [to 06 Nov 2021]
Latest News
No new digest content identified.
Fondation Merieux [to 06 Nov 2021]
News, Events
No new digest content identified.
Gavi [to 06 Nov 2021]
News releases
4 November 2021
Finnish COVAX donation kicks off with shipment to Côte d’Ivoire
GHIT Fund [to 06 Nov 2021]
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that
November 4, 2021
GHIT Fund Announces New Investments: A Total of 750 Million Yen in Drugs for Malaria and Chagas Disease, Vaccine for Malaria, and Diagnostics for Tuberculosis
Global Fund [to 06 Nov 2021]
News & Stories
No new digest content identified.
Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 06 Nov 2021]
Getting COVID-19 research to the right places: a conversation on UKCDR & GloPID-R’s work
When the COVID-19 outbreak was declared, the global research community was forced to react rapidly and the danger of research…

From equity to priority setting: Where we can improve funding epidemic and pandemic research for the future
A report, ‘Funding and undertaking research during the first year of the COVID-19 pandemic: COVID CIRCLE lessons for funders’, published today, presents key lessons and future guidance for research funders to address the challenges of funding and conducting research in the context of an epidemic or pandemic, particularly in low- and middle-income countries (LMICs).

Nearly two years into the COVID-19 pandemic, the global research community has begun to take stock of lessons learned when it comes to funding research during a global health crisis, especially in LMICs.
The report identified a number of barriers experienced by funders and researchers across the globe in the process of undertaking and funding COVID-19 research. These barriers include issues of equity and access, and delays to, and sometimes a lack of, regionally developed research priorities, hindering the alignment of funding and research.

Key lessons for funders from this pandemic that will enable future funding preparedness and response include:
the appreciation of the early development of the WHO & GloPID-R Research Roadmap;
leveraging pre-existing partnerships and funding to enable rapid response;
the need for greater support for open science and data sharing practices in epidemics, along with buy-in and support of LMICs;
the need for greater global funder collaboration.

Many examples of best research practice and innovative funding mechanisms that have taken place during the pandemic to date are featured. Such as the European and Developing Countries, Clinical Trial Partnership (EDCTP) rapid emergency funding mechanism which mobilised €12.75m for research implemented in 25 Sub-Saharan African countries. The report also provides specific recommendations on the actions that funders could pursue, particularly in low-resource settings.

Lessons learned in the report are framed around COVID CIRCLE’s ‘Funder principles for research in epidemics,Funders Principles for Supporting High-Quality Research for the Most Pressing Global Needs in Epidemics and Pandemics’ which build on best practice guidance from key stakeholders and include commitments to ensure that research outputs are shared rapidly to inform policy and practice in epidemic situations. These have been embedded into funding practices e.g. the Global Effort on COVID-19 Health Research (GECO) included adherence to the principles in its funding call guidelines.

The challenges and potential solutions for achieving the Funder Principles require action from a range of stakeholders. The authors of the report issue an urgent call for the Principles to be endorsed by research funders: they call upon donors, governments and any other entities supporting research to address needs during the current as well as future epidemics and pandemics…

Hilleman Laboratories [to 06 Nov 2021]
No new digest content identified.
Human Vaccines Project [to 06 Nov 2021]
No new digest content identified.
IAVI [to 06 Nov 2021]
Latest News
No new digest content identified.


International Coalition of Medicines Regulatory Authorities [ICMRA]
Selected Statements, Press Releases, Research
No new digest content identified.
ICRC [to 06 Nov 2021]
Selected News Releases, Statements, Reports
Reducing Civilian Harm in Urban Warfare: A Commander’s Handbook
We know that urban warfare kills, injures and displaces significantly more civilians – and destroys more critical civilian infrastructure and essential services – than any other combat in open areas.
05-11-2021 | Article

Haiti: The obligation to safeguard health-care services
Port-au-Prince, 26 October 2021 — As armed violence continues to rock Haiti, disruptions to fuel supplies are worsening the already dire humanitarian consequences for its people who struggle to access basic services, including health care.Power cuts
04-11-2021 | News release

DigitHarium Month #8: Cyber operations against humanitarian organizations
For the eighth DigitHarium month, we looked at how cyber operations could affect humanitarian organizations and their work: what the stakes were, what risks were most likely to arise, and what steps humanitarian organizations needed to take.For the e
03-11-2021 | Article


Press Releases/Announcements
No new digest content identified.
IFRC [to 06 Nov 2021]
Selected Press Releases, Announcements
In the race against the pandemic, the poorest, most vulnerable, and marginalized are being left far behind
Statement on COVID-19 vaccine equity from Jagan Chapagain, Secretary General of the International Federation of Red Cross and Red Crescent Societies (IFRC)
“Around half of the world’s population has now received at least one dose of a COVID-19 vaccine. This is a tremendous achievement that even just a year ago seemed unfathomable. However, while richer countries are speeding ahead with vaccination campaigns for their populations, in lower-income countries, only about four per cent of people have received even one dose of a vaccine. Over half of the countries facing humanitarian crises do not have enough doses to vaccinate even ten per cent of their population.
“In the race against the pandemic, the poorest, most vulnerable, and marginalized are being left far behind. It is a humanitarian imperative and a global responsibility, not to mention an economic and recovery necessity, to ensure that everyone has access to vaccines, not only those in countries with the means to buy protection.”
Last week, the UN and the International Red Cross and Red Crescent Movement jointly made five asks to government and the international community, to achieve the equitable distribution and delivery of vaccines.

IFRC President, Francesco Rocca at COP26: “We don’t have anymore time to waste”
Institut Pasteur [to 06 Nov 2021]
Press Documents
No new digest content identified.
IOM / International Organization for Migration [to 06 Nov 2021]
News – Selected
04 Nov 2021
The Race Against Time to Prevent a Humanitarian Disaster in Afghanistan
ISC / International Science Council [to 06 Nov 2021]
ISC is a non-governmental organization with a unique global membership that brings together 40 international scientific Unions and Associations and over 140 national and regional scientific organizations including Academies and Research Councils.
COP26: What does it mean for Cities’ climate action?

Science in Exile podcast: Syrian political scientist Radwan Ziadeh on continuing human rights research and activism across borders

Ten New Insights in Climate Science 2021 report highlights critical research and policy implications for addressing the climate crisis

Can we turn protective seawalls into new natural habitats?

Reforming publishing for more research integrity
IVAC [to 06 Nov 2021]
Updates; Events
No new digest content identified.
IVI [to 06 Nov 2021]
IVI News & Announcements
No new digest content identified.
Johns Hopkins Center for Health Security [to 06 Nov 2021]
Center News
No new digest content identified.
MSF/Médecins Sans Frontières [to 06 Nov 2021]
Latest [Selected Announcements]
Climate emergency
The climate crisis is a health and humanitarian crisis
Project Update 5 Nov 2021
Coronavirus COVID-19 pandemic
Providing support for COVID-19 in Manipur
Project Update 5 Nov 2021

Mediterranean migration
Search and rescue: “They describe Libya as hell”
Voices from the Field 31 Oct 2021
National Academy of Medicine – USA [to 06 Nov 2021]
Selected News/Programs/Events
No new digest content identified.
National Academy of Sciences – USA [to 06 Nov 2021]
No new digest content identified.
National Vaccine Program Office – U.S. HHS [to 06 Nov 2021]
Upcoming Meetings/Latest Updates
No new digest content identified.
NIH [to 06 Nov 2021]
News Releases
NIH scientists identify mechanism that may influence infectivity of SARS-CoV-2 variants
November 5, 2021 — Enzyme process alters spike protein function.

In-person school during COVID-19 must address needs of underserved communities
November 4, 2021 — NIH commentary highlights community engagement in research design and implementation.

When to Test offers free online tool to help individuals make informed COVID-19 testing decisions
November 3, 2021 — The new impact calculator indicates whether a person should get a test.

NIH to study long-term effects of COVID-19 in pregnancy
November 2, 2021 — Effort will follow up to 1,500 pregnant patients with COVID-19 and their offspring for four years.
PATH [to 06 Nov 2021]
Press Releases
No new digest content identified.
Sabin Vaccine Institute [to 06 Nov 2021]
Statements and Press Releases
No new digest content identified.
UNAIDS [to 06 Nov 2021]
Selected Press Releases/Reports/Statements
2 November 2021
Invest in adolescent girls’ and young women’s rights, education and health to end AIDS in Western and Central Africa

1 November 2021
Harm reduction services reduce new HIV infections

1 November 2021
Regional HIV summit aims to reinforce HIV response in Western and Central Africa

UNHCR Office of the United Nations High Commissioner for Refugees [to 06 Nov 2021]
Selected News Releases, Announcements
Libya: First evacuation flight to Niger in over a year brings 172 asylum-seekers to safety
5 Nov 2021


UNHCR urges governments to accelerate progress and resolve plight of world’s stateless
4 Nov 2021


UNHCR begins airlifting aid to Kabul
2 Nov 2021
UNICEF [to 06 Nov 2021]
Press Releases, News Notes, Statements [Selected]
News note
UNICEF analysis finds just 34 per cent of national climate policies are child-sensitive
Geneva Palais briefing note on COP26 and the inclusion of children and young people in climate-related decision-making

News note
FACT SHEET: COP26 – Children and climate change
Unitaid [to 06 Nov 2021]
Featured News
No new digest content identified.
Vaccine Equity Cooperative [nee Initiative] [to 06 Nov 2021]
No new digest content identified.
Vaccination Acceptance & Demand Initiative [Sabin) [to 06 Nov 2021]
No new digest content identified.
Vaccine Confidence Project [to 06 Nov 2021]
News, Research and Reports
Coronavirus global impact
Launched April 2, 2020 and recurring every 3 days, Premise Data is utilizing its global network of Contributors to assess economic, social, and health sentiment surrounding the coronavirus (COVID-19).

Vaccine Education Center – Children’s Hospital of Philadelphia [to 06 Nov 2021]
Vaccine Update Newsletter – October 2021
Vaccine Update is our monthly email newsletter that will keep you up to date on current vaccine-related issues.
Wellcome Trust [to 06 Nov 2021]
News and reports
Global leaders must understand that climate change is a health crisis
Author: Julia Gillard
3 November 2021
The Wistar Institute [to 06 Nov 2021]
Press Releases
No new digest content identified.
WFPHA: World Federation of Public Health Associations [to 06 Nov 2021]
Latest News
No new digest content identified.
World Bank [to 06 Nov 2021]
Selected News, Announcements
Lessons from Remote Learning During COVID-19
“Remote Learning During the Global School Lockdown: Multi-Country Lessons” and “Lessons from Remote Learning During COVID-19: Lessons for today and tomorrow” WHY A TWIN REPORT ON THE IMPACT OF COVID IN…
Date: November 04, 2021 Type: Brief

COVID-19 Responses Could Help Fight Climate Change
WASHINGTON, Nov. 3, 2021 – As the COVID-19 pandemic has overwhelmed health systems worldwide, a new report brings together low-carbon and climate-resilient health solutions that can help protect the planet…
Date: November 03, 2021 Type: Press Release

Supporting Colombian Host Communities and Venezuelan Migrants During the COVID-19 Pandemic
Challenge As of March 2021, an estimated 1.7 million people from Venezuela were based in Colombia— approximately 32 % of all Venezuelan migrants in Latin America. The impact of the crisis is geographically…
Date: October 31, 2021 Type: Result Brief
World Customs Organization – WCO [to 06 Nov 2021]
Latest News – Selected Items
No new digest content identified.
World Organisation for Animal Health (OIE) [to 06 Nov 2021]
Press Releases, Statements
No new digest content identified.
WTO – World Trade Organisation [to 06 Nov 2021]
WTO News and Events
No new digest content identified.



ARM [Alliance for Regenerative Medicine] [to 06 Nov 2021]
Selected Press Releases
The Alliance for Regenerative Medicine Announces Election of 2022 Officers, Executive Committee, and Board of Directors
Washington, DC – October 21, 2021
BIO [to 06 Nov 2021]
Press Releases, Letters, Testimony, Comments [Selected]
No new digest content identified.
DCVMN – Developing Country Vaccine Manufacturers Network [to 06 Nov 2021]
News; Upcoming events
No new digest content identified.
ICBA – International Council of Biotechnology Associations [to 06 Nov 2021]
No new digest content identified.
IFPMA [to 06 Nov 2021]
Selected Press Releases, Statements, Publications
Joint Statement by founding members of AMA Treaty Alliance (AMATA) to welcome the African Medicines
05 November 2021
[See Milestones/Perspective above for detail]


International Generic and Biosimilar Medicines Association [IGBA]
IGBA Calls on all Stakeholders to Join the Biosimilars Movement on Advancing Access
Geneva, November 1st, 2021 – In the week ahead, IGBA will renew its commitment to the collaborative effort to establish worldwide biosimilar policies that deliver better health outcomes and biologics access equity for more patients. The second Global Biosimilars Week will run from 1st to 5th November 2021 on social media, supported by a dedicated website

This awareness campaign is open to all stakeholder contributions worldwide and seeks to gather, under one hashtag #globalbiosimilarsweek, useful ideas, experience, information and resources for and from patients, doctors and all other stakeholders across the healthcare community.

On 2nd November, an online webinar entitled “Unlocking the Global Biosimilar Opportunity in Tackling Non-Communicable Diseases” will provide an additional platform for information and involvement.

The COVID-19 global health crisis has led governments and the entire healthcare community to rethink and rebuild healthcare systems. This includes focusing on their ability to efficiently deliver access to biologic therapies and to effectively address Non-Communicable Diseases (NCDs),” explained Sudarshan Jain, Chair of the IGBA. “Now is a time to reconcile the unique opportunity provided by the availability of biosimilar medicines and the rising challenges for many patients around the world to access quality-assured transformative therapies. We need to redouble the efforts to effectively tackle NCDs and biosimilar medicines are part of the solution.”

“With 15 years of positive biosimilar medicines contribution to patient health and healthcare system sustainability, the challenges and remedies to efficient use of biosimilar medicines are well known. Our new white paper aims to facilitate experience sharing for communities wanting to Advance Access in their country or region and more importantly to implement effective and tailored strategies in tackling Non-Communicable Diseases locally,” said Julie Maréchal-Jamil, Co-Chair of the IGBA Biosimilars Committee.

IGBA companies are the pioneers and global leaders in the development and marketing of biosimilar medicines. To date there have been more than 400 biosimilar approvals in IGBA’s membership jurisdictions, covering more than 10 therapeutic areas including oncology, rheumatoid arthritis, psoriasis, inflammatory bowel disease, growth disorders, nephrology, fertility, diabetes and ophthalmology.

Effective Strategies to Advance Access to Biologic Therapies for Non-Communicable Diseases
A Biosimilar Medicines Access Policy Blueprint
An IGBA Biosimilars Committee White Paper
October 2021 :: 32 pages
International Alliance of Patients’ Organizations – IAPO [to 06 Nov 2021]
Press and media [Selected]
Joint Statement by AMATA welcoming the African Medicines Agency coming into force
November 5, 2021
[See Milestones/Perspective above for detail]
PhRMA [to 06 Nov 2021]
Latest News [Selected]
No new digest content identified.